The Food and Drug Administration has given its blessing to Amphastar Pharmaceuticals for dextrose injection 50% in the 50-ml Luer-Jet Prefilled Syringe System. The medication is a sterile, ...

Amphastar Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Dextrose injection 50% in the 50 ml Luer-Jet Prefilled ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global dextrose injection market is estimated to be valued at US$ 9,512.7 million in 2020 and is expected to exhibit a CAGR of 5.7% ...

The company is recalling the product because of out-of-specification results for high molecular weight polymers. Braun Medical Inc. (B. Braun) is voluntarily recalling one lot of 2g Ceftazidime for ...

Global Dextrose Injection Market 2021 by Company, Regions, Type and Application, Forecast to 2026 added by MarketsandResearch.biz contains an in-depth evaluation of each crucial aspect of the industry ...

Braun Medical Inc. (B. Braun) is voluntarily recalling one (1) lot of 2g Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container to the hospital/user level..

Hikma is offering labetalol hydrochloride 1mg/mL in 200-ml dextrose injection and 100-, 200- and 300-mL in sodium chloride injection. Labetalol HCl in sodium chloride injection and labetalol HCl in ...

This medication is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment, indicated as a source of water, electrolytes and calories or as an alkalinizing agent.

3 Department of Family Medicine, University of Wisconsin, Madison, Wisconsin, USA 4 Department of Radiology, University of Wisconsin, Madison, Wisconsin, USA Purpose To evaluate whether ...

Amphastar Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Dextrose injection 50% in the 50 ml Luer-Jet Prefilled ...